Assessment of Deproteinized Bovine Bone for Immediate Implants Placement in Maxillary Esthetic Zone.
Mohamed sedky
1 other identifier
interventional
16
1 country
1
Brief Summary
: Many of studies have been performed to improve osseointegration and bone density around implants by modifying the implant by adding bone graft or substitute material that increase success of implant. Aim: The aim of this study is to evaluate clinically the efficacy of deproteinized bovine bone in maxillary Esthetic zone to promote bone formation and improve outcomes in immediate implant cases. Methodology: 16 immediate implants will be placed in maxillary esthetic zone. That study will be Conducted on 16 hopeless teeth divided equally and randomly into two groups Randomization will be done using www.randomizer.org ., Group 1: 8 hopeless teeth will be replaced by immediate dental implants represent the (control group) where the implants will be placed without bone graft, Group 2: 8 hopeless teeth will be replaced by immediate dental implants represent the (study group) where the implants will be placed with deproteinized bovine bone graft. The implant stability will be assessed clinically using (Ostell) immediate postoperative and after 6 months and Postoperative pain using visual analogue scale (VAS)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2025
CompletedFirst Submitted
Initial submission to the registry
November 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 5, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 8, 2026
CompletedFirst Posted
Study publicly available on registry
May 6, 2026
CompletedMay 6, 2026
April 1, 2026
11 months
November 23, 2025
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Postoperative Pain (Visual Analog Scale, VAS)
Patients reported the degree of pain using a 10-cm visual analog scale (VAS), where 0 = no pain and 10 = worst possible pain. Pain was assessed at 1, 3, and 7 days postoperatively.
1, 3, and 7 days postoperatively
Visual Scale of Edema
Facial edema was assessed using a visual grading scale: No edema, Low-grade, Intermediate-grade, and High-grade, based on visual inspection and palpation. Edema was evaluated at 1, 3, and 7 days postoperatively.
1, 3, and 7 days postoperatively
Implant Stability (ISQ)
Clinical stability of dental implants was assessed using the Osstell device. The implant stability quotient (ISQ) was measured immediately after implant placement and at 6 months postoperatively. ISQ scores range from 1-100, with scores ≥70 indicating high stability, 60-69 medium stability, and \<60 low stability.
Baseline (immediately after implant placement) and 6 months postoperatively
Peri-implant Bone Density
Bone density around the implants was measured using CBCT radiographs and analyzed with 3D OnDemand software. Measurements were recorded immediately postoperatively and at 6 months.
Baseline (immediately after implant placement) and 6 months postoperatively
Study Arms (2)
Study group : immediate implants placement with deproteinized bovine bone augmentation
ACTIVE COMPARATOR8 hopeless teeth was replaced by immediate dental implants with deproteinized bovine bone augmentation
Control group : Implant implants Placement without bone augmentation
ACTIVE COMPARATOR8 hopeless teeth was replaced by immediate dental implants without bone augmentation
Interventions
8 hopeless teeth was replaced by immediate dental implants without bone augmentation
8 hopeless teeth was replaced by immediate dental implants with deproteinized bovine bone graft.
Eligibility Criteria
You may qualify if:
- Patients with hopeless teeth at maxillary esthetic zone.
- Both genders.
- Middle age adults (from 20 years to 55 years).
- The tooth to be extracted had little to no loss of periodontal bone.
- The tooth where endodontic involvement, root fracture, root resorption, periapical pathology, root perforation
You may not qualify if:
- Medically compromised patient (uncontrolled diabetes, radiotherapy, chemotherapy and hemophilia.
- Patient with bad oral habit as bruxism, heavy smoking over 10 cigarettes a day.
- Patient with bad oral hygiene. 4-Patient with generalized gingival diseases. 5-Patient with generalized periodontal diseases \[with sever vertical or horizontal bone loss\] 6-Teeth with periapical or lateral acute infection or lesions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Suez canal University
Ismailia, 41522, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 23, 2025
First Posted
May 6, 2026
Study Start
January 1, 2025
Primary Completion
December 5, 2025
Study Completion
January 8, 2026
Last Updated
May 6, 2026
Record last verified: 2026-04